CareMax Inc. (CMAX)
CareMax Statistics
Share Statistics
CareMax has 3.81M shares outstanding. The number of shares has increased by 0.32% in one year.
Shares Outstanding | 3.81M |
Shares Change (YoY) | 0.32% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 0.03% |
Shares Floating | 2M |
Failed to Deliver (FTD) Shares | 30.77K |
FTD / Avg. Volume | 8.2% |
Short Selling Information
The latest short interest is 209.53K, so 5.49% of the outstanding shares have been sold short.
Short Interest | 209.53K |
Short % of Shares Out | 5.49% |
Short % of Float | 8.62% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.08 and the forward PE ratio is -0.09. CareMax's PEG ratio is 0.
PE Ratio | -0.08 |
Forward PE | -0.09 |
PS Ratio | 0.07 |
Forward PS | 0 |
PB Ratio | 0.91 |
P/FCF Ratio | -0.91 |
PEG Ratio | 0 |
Enterprise Valuation
CareMax has an Enterprise Value (EV) of 482.14M.
EV / Sales | 0.64 |
EV / EBITDA | -0.82 |
EV / EBIT | -10.28 |
EV / FCF | -7.84 |
Financial Position
The company has a current ratio of 0.42, with a Debt / Equity ratio of 8.01.
Current Ratio | 0.42 |
Quick Ratio | 0.42 |
Debt / Equity | 8.01 |
Debt / EBITDA | -0.83 |
Debt / FCF | -8 |
Interest Coverage | -12.05 |
Financial Efficiency
Return on Equity is -1112.15% and Return on Invested Capital is -117.47%.
Return on Equity | -1112.15% |
Return on Assets | -109.63% |
Return on Invested Capital | -117.47% |
Revenue Per Employee | $518K |
Profits Per Employee | $-471.27K |
Employee Count | 1,450 |
Asset Turnover | 1.21 |
Inventory Turnover | n/a |
Taxes
Income Tax | -863K |
Effective Tax Rate | 0.13% |
Stock Price Statistics
The stock price has increased by -86.92% in the last 52 weeks. The beta is 0.68, so CareMax's price volatility has been higher than the market average.
Beta | 0.68 |
52-Week Price Change | -86.92% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 1.99 |
Relative Strength Index (RSI) | 23.51 |
Average Volume (20 Days) | 375.11K |
Income Statement
In the last 12 months, CareMax had revenue of 751.1M and earned -683.35M in profits. Earnings per share was -183.3.
Revenue | 751.1M |
Gross Profit | 13.9M |
Operating Income | -656.15M |
Net Income | -683.35M |
EBITDA | -590.46M |
EBIT | -629.78M |
Earnings Per Share (EPS) | -183.3 |
Balance Sheet
The company has 65.53M in cash and 491.93M in debt, giving a net cash position of -426.41M.
Cash & Cash Equivalents | 65.53M |
Total Debt | 491.93M |
Net Cash | -426.41M |
Retained Earnings | -720.94M |
Total Assets | 454.04M |
Working Capital | -406.2M |
Cash Flow
In the last 12 months, operating cash flow was -46.91M and capital expenditures -14.61M, giving a free cash flow of -61.52M.
Operating Cash Flow | -46.91M |
Capital Expenditures | -14.61M |
Free Cash Flow | -61.52M |
FCF Per Share | -16.5 |
Margins
Gross margin is 1.85%, with operating and profit margins of -87.36% and -90.98%.
Gross Margin | 1.85% |
Operating Margin | -87.36% |
Pretax Margin | -91.09% |
Profit Margin | -90.98% |
EBITDA Margin | -78.61% |
EBIT Margin | -87.36% |
FCF Margin | -8.19% |
Dividends & Yields
CMAX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1226.07% |
FCF Yield | -110.39% |
Analyst Forecast
Currently there are no analyst rating for CMAX.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 1, 2024. It was a backward split with a ratio of 1:30.
Last Split Date | Feb 1, 2024 |
Split Type | backward |
Split Ratio | 1:30 |
Scores
Altman Z-Score | -7.41 |
Piotroski F-Score | 3 |